Antimicrobial Incentives and Payment Reform

Antimicrobial Incentives and Payment Reform

"If we fail to act, we are looking at an almost unthinkable scenario where antibiotics no longer work and we are cast back into the dark ages of medicine."

David Cameron former UK Prime Minister

Two petri dishes each cultured with bacteria, and each including seven small disks that release antibiotic compounds. The dish on the left evidences effective antimicrobial effects around all seven disks. The dish on the right evidences the bacteria's ability to grow over four of the seven disks, despite the release of antibiotic compounds.

Collaborating to Combat AMR

Over the past year and a half—with support from the Wellcome Trust and others—the Duke-Margolis Center for Health Policy has convened experts from across the AMR landscape to develop domestic policy approaches and identify opportunities for global coordination of promising market incentives.

Research Team

Image of Nicholas Harrison

Nicholas R. Harrison, MPH, MA

Policy Research Associate

David Ridley

David Ridley, PhD

Professor of the Practice of Business and Economics
Margolis Executive Core Faculty

"AMR is a slow tsunami that threatens to undo a century of medical progress."

Dr. Tedros Adhanom Ghebreyesus Director General, World Health Organization